Sclerosing Epithelioid Fibrosarcoma of the Bone With Rare EWSR1-CREB3L3 Translocation Driving Upregulation of the PI3K/mTOR Signaling Pathway.
Archana ShenoyLea SurreyPayal JainJessica FosterJoshua StrakaAdam ResnickAngela WaandersMinjie LuoMarilyn LiKen KazahayaRochelle BagatellJohn WojcikJennifer PogorilerPublished in: Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society (2019)
Sclerosing epithelioid fibrosarcoma (SEF) is an uncommon neoplasm that rarely presents in bone. It is characterized by epithelioid cells arranged in nests and single-file cords within a sclerotic stromal background which may mimic neoplastic bone. SEF harbors an EWSR1 translocation, which may complicate its distinction from Ewing sarcoma in cases with histomorphologic overlap. We present a diagnostically challenging case of SEF in the mandible of a 16-year-old girl. Our experience highlights the lack of specificity of traditional morphology and EWSR1 break-apart fluorescent in situ hybridization. Open-ended RNA-based fusion gene testing coupled with MUC4 immunohistochemistry aided the eventual diagnosis in this case. Herein, we report the third case of SEF with EWSR1-CREB3L3 translocation and show that this fusion leads to aberrant upregulation of the phosphoinositide 3-kinase/mammalian target of rapamycin signaling pathway in heterologous cell models.
Keyphrases
- signaling pathway
- induced apoptosis
- bone mineral density
- cell proliferation
- pi k akt
- epithelial mesenchymal transition
- bone loss
- soft tissue
- poor prognosis
- bone regeneration
- bone marrow
- stem cells
- cell therapy
- minimally invasive
- genome wide
- single cell
- body composition
- tyrosine kinase
- mesenchymal stem cells
- dna methylation
- gene expression
- cell death